marcescens, while the latter include Staphylococcus aureus and S pneumoniae. In more severe cases, Pseudomonas and Acinetobacter species must also be included.
The predominance of Gram-negative bacilli as causative pathogens in nosocomial cases relates to changes in the nature of the bacteria that colonize the oropharynx of individuals with underlying disease and to the mechanisms by which pathogens reach the lung. Bacteria may gain access to the lower respiratory tract by a variety of means, including inhalation, hematogenous spread, translocation from the gastrointestinal tract and aspiration. Of these, aspiration is the most common.
Gram-negative bacilli colonize the oropharynx of fewer than 10% of healthy people; however, this figure jumps to 75% in those who are critically ill (4) . The net result is that ill individuals aspirate much more virulent organisms during sleep than do healthy individuals, with pneumonia being one of the possible outcomes.
Changes in the epidemiology of pneumonia are evident in CAP and nosocomial cases. In the former, there appears to be a higher incidence of infection with so-called atypical pathogens such as M pneumoniae and C pneumoniae, while in nosocornial cases, infection with multiply resistant Gram-negative bacilli and methicillin-resistant S aureus are becoming increasingly important.
The diagnosis of pneumonia is certainly far from straightforward. In CAP cases, it was often taught that certain symptoms, such as a cough productive of purulent sputum and pleuritic chest pain, were suggestive of 'typical' pneumonia as might be caused by classic bacterial pathogens such as S pneumoniae. On the other hand, symptoms such as a nonproductive cough or a cough productive of mucoid sputum were suggestive of 'atypical' pneumonia and infection with organisms such as M pneumoniae or C pneumoniae. A study by Fang et al (5) , however, showed that the etiological agent could not be determined based on the clinical symptoms or physical signs.
In HAP cases, the physician is not only faced with a wide variety of possible pathogens to consider but also must often differentiate between infective and noninfective causes of fever and pulmonary infiltrates such as pulmonary emboli, adult respiratory distress syndrome and pulmonary drug reactions.
Given these considerations, it is clear that developing guidelines for initial treatment regimens of pneumonia is not a straightforward task. A variety of approaches was carefully considered, but ultimately it was felt that, to be useful, the approach chosen must be based on variables that are likely to predict specific pathogens and the patient' s clinical course.
The variables used as the basis for initial treatment of CAP and HAP are, first for CAP:
• the severity of illness upon clinical presentation;
• whether the pneumonia was acquired in the community setting or in a nursing home;
• the presence or absence of comorbid illness (or age older than 65 years); and
• whether treatment is to be given in the community setting, the nursing home or following admission of the patient to a hospital. and for HAP:
• mild to moderate pneumonia with no unusual risk factors;
• mild to moderate pneumonia with risk factors; and • severe pneumonia. The guidelines offer a number of possible regimens for the various clinical scenarios. One could argue that fewer choices should have been offered or that more specific regimens should have been selected. It is apparent, however, that there is some regional or geographic variation in terms of epidemiological patterns as well as susceptibilities of microorganisms to various antimicrobials. By providing a number of alternatives, the individual physician can then choose the best possible regimen, keeping in mind the local factors that may influence the choice of drugs. It is stressed that these are meant as guidelines only for initial antimicrobial management and should be modified when necessary if appropriate culture and sensitivity results become available.
Since pneumonia is a difficult disease to diagnose and treat, physicians have found its management frustrating, to say the least. Because of their pragmatic and practical approach, these guidelines have been extremely well received by family physicians and specialists alike. Using the Canadian guidelines as a foundation, the American Thoracic Society recently published its own guidelines for CAP and is currently developing nosocomial pneumonia guidelines, which are also based on the Canadian document (1,2,6 ).
